A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients

OBJECTIVE: In Japan, there had been no prospective clinical studies conducted in terms of modified FOLFOX6 + bevacizumab therapy. We performed a post-marketing Phase II multicenter clinical study to examine the efficacy and safety of this regimen as first-line therapy for Japanese patients with adva...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Main Authors:	Nishina, Tomohiro, Takano, Yoshinao, Denda, Tadamichi, Yasui, Hisateru, Takeda, Koji, Ura, Takashi, Esaki, Taito, Okuyama, Yusuke, Kondo, Ken, Takahashi, Yasuo, Sugiyama, Yasuyuki, Muro, Kei
Format:	Artigo
Sprog:	Inglês
Udgivet:	Oxford University Press 2013
Fag:	Original Articles
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3814899/ https://ncbi.nlm.nih.gov/pubmed/23999770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyt127
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients

Lignende værker